Diabetic cardiovascular disease--AMP-activated protein kinase (AMPK) as a therapeutic target

scientific article published on September 2012

Diabetic cardiovascular disease--AMP-activated protein kinase (AMPK) as a therapeutic target is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2174/187152512802651015
P698PubMed publication ID22632264

P2093author name stringMarie-Ann Ewart
Simon Kennedy
P433issue3
P304page(s)190-211
P577publication date2012-09-01
P1433published inCardiovascular & hematological agents in medicinal chemistryQ27721058
P1476titleDiabetic cardiovascular disease--AMP-activated protein kinase (AMPK) as a therapeutic target
P478volume10

Reverse relations

cites work (P2860)
Q59133291A facile synthesis of 5'-fluoro-5'-deoxyacadesine (5'-F-AICAR): a novel non-phosphorylable AICAR analogue.
Q36288862Alterations of specific biomarkers of metabolic pathways in vascular tree from patients with Type 2 diabetes
Q35786918Anthocyanin-rich Seoritae extract ameliorates renal lipotoxicity via activation of AMP-activated protein kinase in diabetic mice
Q48042214How AMPK and PKA Interplay to Regulate Mitochondrial Function and Survival in Models of Ischemia and Diabetes
Q38829598New synthetic AICAR derivatives with enhanced AMPK and ACC activation
Q92128838Small molecule IVQ, as a prodrug of gluconeogenesis inhibitor QVO, efficiently ameliorates glucose homeostasis in type 2 diabetic mice
Q42278323Synthesis of new acadesine (AICA-riboside) analogues having acyclic D-ribityl or 4-hydroxybutyl chains in place of the ribose.
Q42137439The hypotensive effect of acute and chronic AMP-activated protein kinase activation in normal and hyperlipidemic mice

Search more.